1,522 results · 16ms · Sources: EU EUDAMED, US FDA

VID82-

Basic UDI-DI
EU IVDD · Eu Ivd General ·VivaChek Biotech (Hangzhou) Co., Ltd.·1 device

VID83-

Basic UDI-DI
EU IVDD · Eu Ivd General ·VivaChek Biotech (Hangzhou) Co., Ltd.·1 device

IRTA1 (QM005)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Inhibin alpha (QR088)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgG4 (QR092)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgA (QR050)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgA (QR050)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

IgA (QR050)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market